-
1
المؤلفون: Ripping, T. M., Rammant, E., Witjes, J. A., Aaronson, N. K., van Hemelrijck, M., van Hoogstraten, L. M.C., Boormans, J., Goossens, C. A., van der Heijden, A. G., Hulshof, M. C.C.M., van Leenders, G. J.L.H., van Leliveld, A. M., Meijer, R. P., van Moorselaar, R. J.A., Mulder, S. F., Nooter, R. I., Noteboom, J. L., Oddens, J. R., de Reijke, T. M., van Rhijn, B. W.G., van Roermund, J. G.H., Smilde, T. J., Vanderbosch, G. W.J., Wijsman, B. P., Kiemeney, L. A., Aben, K. K.H.
المساهمون: Radiotherapy, CCA - Cancer Treatment and Quality of Life, Urology, APH - Quality of Care, APH - Personalized Medicine, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers
المصدر: BlaZIB Study Group 2022, ' Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer ', Health and Quality of Life Outcomes, vol. 20, no. 1, 171 . https://doi.org/10.1186/s12955-022-02064-z
Health and quality of life outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20(1):171. BioMed Central
Health and Quality of Life Outcomes, 20, 1
Health and Quality of Life Outcomes, 20مصطلحات موضوعية: Quality of life, Patient-reported outcomes measures, Validation studies, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Bladder cancer, Public Health, Environmental and Occupational Health, General Medicine, EORTC questionnaire
وصف الملف: application/pdf